Selected article for: "clinical decision making evidence support and decision making"
Author: Russell, Beth; Moss, Charlotte; Papa, Sophie; Irshad, Sheeba; Ross, Paul; Spicer, James; Kordasti, Shahram; Crawley, Danielle; Wylie, Harriet; Cahill, Fidelma; Haire, Anna; Zaki, Kamarul; Rahman, Fareen; Sita-Lumsden, Ailsa; Josephs, Debra; Enting, Deborah; Lei, Mary; Ghosh, Sharmistha; Harrison, Claire; Swampillai, Angela; Sawyer, Elinor; D'Souza, Andrea; Gomberg, Simon; Fields, Paul; Wrench, David; Raj, Kavita; Gleeson, Mary; Bailey, Kate; Dillon, Richard; Streetly, Matthew; Rigg, Anne; Sullivan, Richard; Dolly, Saoirse; Van Hemelrijck, Mieke
Title: Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in London
  • Cord-id: zziwb2jy
  • Document date: 2020_7_22
    • ID: zziwb2jy
    Snippet: Background: There is insufficient evidence to support clinical decision-making for cancer patients diagnosed with COVID-19 due to the lack of large studies. Methods: We used data from a single large UK Cancer Center to assess the demographic/clinical characteristics of 156 cancer patients with a confirmed COVID-19 diagnosis between 29 February and 12 May 2020. Logistic/Cox proportional hazards models were used to identify which demographic and/or clinical characteristics were associated with COV
    Document: Background: There is insufficient evidence to support clinical decision-making for cancer patients diagnosed with COVID-19 due to the lack of large studies. Methods: We used data from a single large UK Cancer Center to assess the demographic/clinical characteristics of 156 cancer patients with a confirmed COVID-19 diagnosis between 29 February and 12 May 2020. Logistic/Cox proportional hazards models were used to identify which demographic and/or clinical characteristics were associated with COVID-19 severity/death. Results: 128 (82%) presented with mild/moderate COVID-19 and 28 (18%) with a severe case of the disease. An initial cancer diagnosis >24 months before COVID-19 [OR: 1.74 (95% CI: 0.71–4.26)], presenting with fever [6.21 (1.76–21.99)], dyspnea [2.60 (1.00–6.76)], gastro-intestinal symptoms [7.38 (2.71–20.16)], or higher levels of C-reactive protein [9.43 (0.73–121.12)] were linked with greater COVID-19 severity. During a median follow-up of 37 days, 34 patients had died of COVID-19 (22%). Being of Asian ethnicity [3.73 (1.28–10.91)], receiving palliative treatment [5.74 (1.15–28.79)], having an initial cancer diagnosis >24 months before [2.14 (1.04–4.44)], dyspnea [4.94 (1.99–12.25)], and increased CRP levels [10.35 (1.05–52.21)] were positively associated with COVID-19 death. An inverse association was observed with increased levels of albumin [0.04 (0.01–0.04)]. Conclusions: A longer-established diagnosis of cancer was associated with increased severity of infection as well as COVID-19 death, possibly reflecting the effects a more advanced malignant disease has on this infection. Asian ethnicity and palliative treatment were also associated with COVID-19 death in cancer patients.

    Search related documents:
    Co phrase search for related documents
    • abnormal value and logistic regression: 1, 2, 3, 4, 5, 6
    • abnormal value and logistic regression analysis: 1
    • abnormal value and long follow study: 1
    • acute ards respiratory distress syndrome and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and logistic regression analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • acute ards respiratory distress syndrome and long follow study: 1
    • acute ards respiratory distress syndrome and low lymphocyte count: 1, 2
    • acute ards respiratory distress syndrome and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • acute ards respiratory distress syndrome and lung cancer incidence: 1
    • acyclic graph and logistic regression: 1, 2, 3
    • logistic regression analysis and low tertile: 1
    • logistic regression and long follow study: 1, 2, 3, 4
    • logistic regression and low albumin level: 1, 2, 3, 4
    • logistic regression and low category: 1, 2, 3, 4, 5, 6, 7
    • logistic regression and low lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • logistic regression and low middle high: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • logistic regression and low middle high socioeconomic status: 1
    • logistic regression and low tertile: 1, 2, 3
    • logistic regression and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25